Neural Therapeutics Inc. (CSE:NURL)

Canada flag Canada · Delayed Price · Currency is CAD
0.0150
0.00 (0.00%)
At close: Feb 24, 2026
-50.00%
Market Cap 2.53M
Revenue (ttm) n/a
Net Income (ttm) -989.97K
Shares Out 168.70M
EPS (ttm) -0.01
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 11,000
Average Volume 89,358
Open 0.0150
Previous Close 0.0150
Day's Range 0.0150 - 0.0150
52-Week Range 0.0100 - 0.0500
Beta n/a
RSI 47.28
Earnings Date Mar 30, 2026

About Neural Therapeutics

Neural Therapeutics Inc., an ethnobotanical drug discovery and development company, develops over-the-counter dietary supplements and psychedelic-based therapeutic drugs to treat mental illnesses in Canada. The company utilizes psychoactive plants, such as San Pedro, a cactus containing mescaline, for the creation of plant-based traditional medicine. Its products target substance use disorders, including alcohol and opioid dependence. The company was formerly known as Psychedelic Science Corp. and changed its name to Neural Therapeutics Inc. in... [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 2020
Country Canada
Stock Exchange Canadian Securities Exchange
Ticker Symbol NURL
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.